Drug Prevention vs. Treatment: A Cost-Effectiveness Analysis

Introduction: Prevention as Policy Principle

"Prevention is better than cure" is an age-old and time-tested maxim that has been proved correct in many different situations. Nowhere is this more apparent than in the area of drug abuse: it is far easier and more cost-effective to prevent drug use than to treat it. This essay explains why drug treatment is far more expensive than drug prevention, drawing on federal budget data and key research reports to make the case.

Economic Cost of Drug and Alcohol Abuse

A study by the Lewin Group for the National Institute on Drug Abuse (NIDA) estimated the total economic cost of alcohol and drug abuse in the United States at $245.7 billion for 1992 ("NIDA InfoFacts," 2005). This figure includes productivity losses (from premature death and drug abuse-related illnesses), health costs, and other primarily crime-related costs, such as losses due to incarceration and criminal careers. It is worth noting that the 1992 cost estimate had already increased 50% over the 1985 estimate, meaning the current economic cost of drug abuse is likely far higher.

If we consider a hypothetical scenario in which all alcohol and drug abuse in the United States were prevented, we would theoretically save approximately $245.7 billion. By contrast, treatment of drug abuse alone can at best recover only a small fraction of that total — and only if the savings from rehabilitating a reformed drug user exceed the cost of the treatment itself. The fundamental difference is this: treatment occurs after economic damage to society has already been done, whereas prevention stops the problem before any cost materializes.

Federal Spending on Prevention vs. Treatment

The scale of expenditures involved in prevention and treatment is reflected directly in the federal budget. President Bush's 2003 budget, for example, included $19.2 billion in total anti-drug spending. Of that amount, $644 million was allocated to federal prevention programs promoting drug-free schools and communities, and $180 million was directed toward advertising campaigns highlighting the hazards of drug use among youth. By comparison, federal spending on treatment and related research totaled $3.8 billion (Keen, 2002). It should also be noted that the prevention figures do not include the far more expensive interdiction costs — programs designed to stop drugs from entering the United States — which were budgeted at $2.3 billion for 2003 alone.

When we factor in the role of parental guidance in keeping young people away from drugs, the cost-effectiveness of prevention increases further still. Such counseling often comes at no direct financial cost — it requires only that parents are aware of the prevalence of drug use among children and understand the dangers it poses to their health and future. This kind of informal prevention represents a substantial, largely unquantified benefit that strengthens the economic argument for prevention-first approaches to drug policy.

Conclusion

The cost of drug and alcohol abuse to society is, no doubt, staggering. Prevention and treatment of drug use are both aimed at a common objective: controlling drug abuse. Of the two strategies, however, drug treatment is far more expensive — both in direct program costs and in the societal damage that has already occurred by the time treatment becomes necessary. The evidence from federal budgets and research studies consistently supports the conclusion that investing in prevention offers a far greater return than investing in treatment alone.